
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1144 | 1097 | 1185 | 1589 | 2222 | 1832 |
Fund Return | 14.42% | 9.72% | 18.52% | 16.7% | 17.32% | 6.24% |
Place in category | 139 | 136 | 70 | 2 | 14 | 31 |
% in Category | 35 | 34 | 21 | 1 | 4 | 12 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Brandes International Small Cap EqI | 827.31M | 16.43 | 27.44 | 8.73 | ||
Brandes Emerging Markets Value I | 485.03M | 7.71 | 10.72 | 2.98 | ||
Brandes Emerging Markets Value A | 171.37M | 2.51 | 3.28 | 2.99 | ||
Brandes International Small Cap Equ | 106.5M | 3.68 | 18.04 | 8.46 | ||
Brandes International Equity Fund A | 106.28M | 4.23 | 8.64 | 6.19 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Dodge & Cox International Stock | 39.93B | 11.94 | 10.26 | 4.78 | ||
Fidelity Series International VVV | 15.5B | 18.20 | 15.00 | 6.62 | ||
Causeway International Value Instl | 13.32B | 11.48 | 15.01 | 5.76 | ||
Vanguard International Value Inv | 11.94B | 6.02 | 7.04 | 4.30 | ||
DFA International Value I | 9.99B | 13.39 | 12.57 | 5.94 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Takeda Pharmaceutical | JP3463000004 | 2.91 | 4,018.0 | -5.10% | |
Heineken | NL0000008977 | 2.54 | 70.50 | +0.64% | |
Sanofi | FR0000120578 | 2.49 | 92.92 | +1.26% | |
GSK plc | GB00BN7SWP63 | 2.48 | 1,377.50 | +0.99% | |
Alibaba | KYG017191142 | 2.41 | 126.50 | +2.35% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review